Jennifer Lai

Appearances

PREDICTING POST-LIVER TRANSPLANT (LT) OUTCOMES IN ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) PATIENTS USING EXPERT-AUGMENTED MACHINE LEARNING (EAML)
Date
May 9, 2023
BACKGROUND: Due to development of an immune dysregulated phenotype, advanced liver disease in all its forms predisposes to sepsis acquisition and related mortality…
Presenter
Jin Ge
University of California, San Francisco
Speakers
Jean Digitale
Charles E. McCulloch
Mark Pletcher
Jennifer Lai
Efstathios Gennatas
THE LIVER FRAILTY INDEX (LFI) IMPROVES MORTALITY RISK PREDICTION OVER MELD 3.0 ALONE FOR WOMEN, OLDER ADULTS, AND OBESE PATIENTS WITH CIRRHOSIS
Date
May 20, 2024
BACKGROUND: The Model for End-Stage Liver Disease-Sodium (MELDNa) is an established metric of 3-month waitlist mortality (WLM) in cirrhosis patients but underestimates mortality risk in certain subgroups…
Presenter
Melinda Wang
Speakers
Amy Shui
Jessica Ruck
Matthew Kappus
Elizabeth Verna
Daniel Ganger
Elizabeth King
Daniela Ladner
Amit Tevar
Michael Volk
Andres Duarte-Rojo
University of Arkansas for Medical Sciences
Chiung-Yu Huang
Robert Rahimi
Jennifer Lai
PERFORMANCE AND NUTRITIONAL STATUS ARE EACH INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA RECEIVING IMMUNOTHERAPY
Date
May 20, 2024
Management of advanced hepatocellular carcinoma (HCC) has been transformed by immune checkpoint inhibitors (ICIs), which are now first-line systemic therapies…
Presenter
Madeleine Hu
Speakers
R. Kate Kelley
Jennifer Lai
Michael Li